Nanoparticles for gene delivery: Therapeutic and toxic effects

Molecular and Cellular Toxicology

Volumn 10, Issue 1, 2014, Pages 1-8

  Choi, Young Suk ^a   Lee, Mi Young ^b   David, Allan E ^a   Park, Yoon Shin ^c  

^a AUBURN UNIVERSITY   (United States)

^b Soonchunhyang University   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

Cytotoxicity; Gene Delivery; Gene Therapy; Nanoparticles; Targeting

Indexed keywords

AMMONIUM CHLORIDE; APATITE; CARBON NANOTUBE; CHITOSAN; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; FERRIC OXIDE; GOLD NANOPARTICLE; MACROGOL; MAGNETIC NANOPARTICLE; MAGNETITE NANOPARTICLE; MULTI WALLED NANOTUBE; NAKED DNA; NANOPARTICLE; PLASMID DNA; POLYAMIDOAMINE; POLYETHYLENEIMINE; QUANTUM DOT; REACTIVE OXYGEN METABOLITE; RNA; SMALL INTERFERING RNA; SOLID LIPID NANOPARTICLE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; CYCLOADDITION; DNA TRANSFECTION; DRUG SAFETY; ELECTROPORATION; GENE EXPRESSION; GENE GUN; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GENOTOXICITY; HUMAN; HYDRODYNAMICS BASED TRANSFECTION; IMMUNE RESPONSE; JET INJECTION; LIPOSOMAL GENE DELIVERY SYSTEM; NEEDLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OXIDATIVE STRESS; POLYMERIZATION; RETROVIRUS; REVIEW;

EID: 84901231365     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-014-0001-3     Document Type: Review

References (60)

1. Thomas, M. & Klibanov, A. M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 62:27-34 (2003).
2. Seow, Y. & Wood, M. J. Biological gene delivery vehicles: beyond viral vectors. Mol Ther 17:767-777 (2009).
3. Takakura, Y., Nishikawa, M., Yamashita, F. & Hashida, M. Development of gene drug delivery systems based on pharmacokinetic studies. Eur J Pharm Sci 13:71-76 (2001).
4. Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432:173-178 (2004).
5. Kawabata, K., Takakura, Y. & Hashida, M. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm Res 12:825-830 (1995).
6. Liu, F., Shollenberger, L. M. & Huang, L. Non-immunostimulatory nonviral vectors. FASEB J 18: 1779-1781 (2004).
7. Jayakumar, R. et al. Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydrate Polymers 79: 1-8 (2010).
8. Mohanraj, V. & Chen, Y. Nanoparticles-a review. Trop J Pharm Res 5:561-573 (2007).
9. Langer, R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res 33:94-101 (2000).
10. Al-Dosari, M. S. & Gao, X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 11:671-681 (2009).
11. Walther, W. & Stein, U. Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 60:249-271 (2000).
12. Young, L. S. & Mautner, V. The promise and potential hazards of adenovirus gene therapy. Gut 48:733-736 (2001).
13. Fischer, D. et al. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16: 1273-1279 (1999).
14. Wolff, J. A. et al. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468 (1990).
15. Glasspool-Malone, J. & Malone, R. W. Marked enhancement of direct respiratory tissue transfection by aurintricarboxylic acid. Hum Gene Ther 10:1703-1713 (1999).
16. Wendell, D. M. et al. The effect of jet parameters on jet injection. Conf Proc IEEE Eng Med Biol Soc 1: 5005-5008 (2006).
17. Lysakowski, C., Dumont, L., Tramèr, M. R. & Tassonyi, E. A needle-free jet-injection system with lidocaine for peripheral intravenous cannula insertion: a randomized controlled trial with cost-effectiveness analysis. Anesth Analg 96:215-219, table of contents (2003).
18. Liu, F., Song, Y. & Liu, D. Hydrodynamics- based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6:1258-1266 (1999).
19. Zhang, G. et al. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther 11 : 675-682 (2004).
20. André, F. & Mir, L. M. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 11 Suppl 1:S33-42 (2004).
21. Sakai, M. et al. Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation. Gene Ther 12:607-616 (2005).
22. Uchida, M. et al. Effects of particle size, helium gas pressure and microparticle dose on the plasma concentration of indomethacin after bombardment of indomethacin-loaded poly-L-lactic acid microspheres using a Helios gun system. Biol Pharm Bull 25:690-693 (2002).
23. Lian, B. et al. Induction of immune responses in ducks with a DNA vaccine encoding duck plague virus glycoprotein C. Virol J 8:214 (2011).
24. Nemeckova, S. et al. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules. Neoplasma 54:326-333 (2007).
25. Nguyen-Hoai, T. et al. HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunity. Oncoimmunology 1:1537-1545 (2012).
26. Goudy, K. S., Wang, B. & Tisch, R. Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice. Clin Immunol 129:49-57 (2008).
27. Jin, S., Leach, J. C. & Ye, K. Nanoparticle-mediated gene delivery. Methods Mol Biol 544:547-557 (2009).
28. Vinogradov, S. V., Bronich, T. K. & Kabanov, A. V. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev 54:135-147 (2002).
29. Peppas, N. A., Panyam, J. & Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 64:61-71 (2012).
30. Chen, G., Takezawa, M., Kawazoe, N. & Tateishi, T. Preparation of cationic gold nanoparticles for gene delivery. Open Biotechnol J 2:152-156 (2008).
31. Sandhu, K. K. et al. Gold nanoparticle-mediated trasfection of mammalian cells. Bioconjug Chem 13:3-6.
32. Mah, C. et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mol Ther 6:106-112 (2002).
33. Kami, D. et al. Application of magnetic nanoparticles to gene delivery. Int J Mol Sci 12:3705-3722 (2011).
34. Maes, R., Sedwick, W. & Vaheri, A. Interaction between DEAE-dextran and nucleic acids. Biochim. Biophys Acta - Nucleic Acids Protein Synth 134:269-276 (1967).
35. Ziady, A.-G. et al. Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo. Mol Ther 8:936-947 (2003).
36. Forrest, M. L., Koerber, J. T. & Pack, D. W. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem 14:934-940.
37. Mintzer, M. A. & Simanek, E. E. Nonviral vectors for gene delivery. Chem Rev 109:259-302 (2009).
38. Olbrich, C. et al. Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Release 77:345-355 (2001).
39. Rudolph, C. et al. Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. Pharm Res 21:662-669 (2004).
40. Delgado, D. et al. New gene delivery system based on oligochitosan and solid lipid nanoparticles: "in vitro" and "in vivo" evaluation. Eur J Pharm Sci 50: 484-491 (2013).
41. Balazs, D. A. & Godbey, W. Liposomes for use in gene delivery. J Drug Deliv 2011:326497 (2011).
42. Zuidam, N. J. & Barenholz, Y. Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Biochim Biophys Acta 1368:115-128 (1998).
43. Kim, J.-K. et al. Enhancement of polyethylene glycol (PEG)- modified cationic liposome- mediated gene deliveries: effects on serum stability and transfection efficiency. J Pharm Pharmacol 55:453-460 (2003).
44. Kim, J. et al. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc 128:688-689 (2006).
45. Atabaev, T. S. et al. Mesoporous silica with fibrous morphology: a multifunctional core-shell platform for biomedical applications. Nanotechnology 24:345603 (2013).
46. Gao L. & Ma N. DNA- templated semiconductor nanocrystal growth for controlled DNA packing and gene delivery. ACS Nano 6:689-695 (2012)
47. Chowdhury, E. H. & Akaike, T. A bio-recognition device developed onto nano- crystals of carbonate apatite for cell-targeted gene delivery. Biotechnol Bioeng 90:414-421 (2005).
48. Chen, C. et al. EGF- functionalized single- walled carbon nanotubes for targeting delivery of etoposide. Nanotechnology 23:045104 (2012).
49. Klumpp, C., Kostarelos, K., Prato, M. & Bianco, A. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim Biophys Acta 1758:404-412 (2006).
50. Pantarotto, D. et al. Functionalized Carbon Nanotubes for Plasmid DNA Gene Delivery. Angew Chemie 116: 5354-5358 (2004).
51. Singh, R. et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc 127:4388-4396 (2005).
52. Lee, S. B. et al. Antibody-based bio-nanotube membranes for enantiomeric drug separations. Science 296:2198-2200 (2002).
53. Chen, C.-C. et al. Preparation of fluorescent silica nanotubes and their application in gene delivery. Adv Mater 17:404-407 (2005).
54. Chen, W., Turro, N. J. & Tomalia, D. A. Using Ethidium Bromide To Probe the Interactions between DNA and Dendrimers. Langmuir 16:15-19 (2000).
55. Topp, A. et al. Probing the location of the terminal groups of dendrimers in dilute solution. Macromolecules 32:7226-7231 (1999).
56. Kabanov, V. A. et al. Interpolyelectrolyte complexes formed by DNA and astramol Poly(propylene imine) dendrimers. Macromolecules 33:9587-9593 (2000).
57. Lewinski, N., Colvin, V. & Drezek, R. Cytotoxicity of nanoparticles. Small 4:26-49 (2008).
58. De Jong, W. H. & Borm, P. J. A. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3:133-149 (2008).
59. Donaldson, K. et al. Nanoparticles and the cardiovascular system: a critical review. Nanomedicine (Lond). 8:403-423 (2013).
60. Buzea, C., Pacheco, I. I. & Robbie, K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2:MR17 (2007).